主页 > 医学新闻 >
【medical-news】艾滋病与耐药性结核有关
Nov 16, 2006, 18:09 GMT
NEW HAVEN, CT, United States (UPI) -- U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.
Yale School of Medicine researchers aiming to integrate HIV and TB care and treatment note TB is the most common cause of death and illness in those with HIV infection in sub-Saharan Africa. Death rates of up to 40 percent annually have been reported in patients with both HIV and TB.
Senior author Dr. Gerald Friedland, director of the AIDS program at Yale, said the issue is of grave worldwide importance, with multi-drug resistant tuberculosis and extensively drug-resistant tuberculosis threatening to blunt or reverse the success of TB programs and the roll-out of anti-retroviral HIV therapies in resource limited settings.
Friedland says there is a desperate need for new TB diagnostic tests and treatments.
'It is still being diagnosed the same way it was in 1882,' he said. 'Modern technology for diagnosis and new treatment needs to be developed urgently. The last approved TB drug was 40 years ago.'
The 5-year study appeared in the Oct. 26 issue of The Lancet.
http://news.monstersandcritics.com/health/article_1222853.php/HIV_AIDS_linked_to_drug_resistant_TB 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 HIV/AIDS linked to drug resistant TB
Nov 16, 2006, 18:09 GMT
艾滋病与耐药性结核有关
格林威治平均时间2006年11月16日，18：09
NEW HAVEN, CT, United States (UPI) -- U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.
纽黑文，CT，美国（合众社）——美国科学家称在南非乡村进行的一项研究显示，一类高耐药性结核与艾滋病（HIV/AIDS）有关。
Yale School of Medicine researchers aiming to integrate HIV and TB care and treatment note TB is the most common cause of death and illness in those with HIV infection in sub-Saharan Africa. Death rates of up to 40 percent annually have been reported in patients with both HIV and TB.
耶鲁大学医学院的研究者们正在使艾滋病和结核的治疗相统一，他们发现结核是导致沙哈拉沙漠以南的非洲地区HIV感染患者死亡和患病的最常见原因。同时为艾滋病和结核病的患者每年的死亡率高?0%。
Senior author Dr. Gerald Friedland, director of the AIDS program at Yale, said the issue is of grave worldwide importance, with multi-drug resistant tuberculosis and extensively drug-resistant tuberculosis threatening to blunt or reverse the success of TB programs and the roll-out of anti-retroviral HIV therapies in resource limited settings.
耶鲁大学艾滋病项目主管，本研究作者Gerald Friedland博士说，该结论具有全球性的重要意义，多重耐药性和广谱耐药性结核菌使结核防治计划的成功受到被颠覆或挫折的威胁，也使资源有限地区的抗逆转录病毒（HIV）治疗无法开展。
Friedland says there is a desperate need for new TB diagnostic tests and treatments.
Friedland说现在迫切需要一套新的结核诊断和治疗方法。
'It is still being diagnosed the same way it was in 1882,' he said. 'Modern technology for diagnosis and new treatment needs to be developed urgently. The last approved TB drug was 40 years ago.'
“现在仍沿用着与1882年相同的诊断方法，”他说，“非常需现代化的诊断技术和全新的治疗方法。而最新的一种抗结核药是40年前研制的。”
The 5-year study appeared in the Oct. 26 issue of The Lancet.
该项研究发表在10月26日的Lancet杂志上。
背景材料下载PDF：WHO HIV/AIDS programme--ANTIRETROVIRAL THERAPY FOR HIV INFECTION IN ADULTS AND ADOLESCENTS IN RESOURCE-LIMITED SETTINGS: TOWARDS UNIVERSAL ACCESS
阅读本文的人还阅读：
作者:admin@医学,生命科学 2010-10-07 23:53
医学,生命科学网